Novartis and Bausch & Lomb's co-promote Retisert
This article was originally published in Clinica
Executive Summary
Bausch & Lomb (B&L) has enlisted the help of Novartis Ophthalmics, the eye business unit of pharmaceuticals giant Novartis, to promote its Retisert corticosteriod-releasing intravitreal implant in the US. Under the terms of the agreement, Novartis will supplement B&L's own sales effort by promoting the product to its network of retinal specialists. Rochester, New York-based B&L will retain responsibility for marketing and product strategy.